UBS Group
NMHI

UBS Group’s Natures Miracle Holding Inc. Common Stock NMHI Stock Holding History

UBS Group’s Portfolio NMHI Stock Details NMHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,624
Closed -$15.1K – 10663
2024
Q3 		$15.1K Buy
+3,624
New +$26.4K ﹤0.01% 7523

Other funds holding NMHI

CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group's NMHI Position: Q4 2024 in Review

UBS Group sold out of Natures Miracle Holding Inc. Common Stock (NMHI) in Q4 2024, closing a stake of 3,624 shares — an estimated $15.1K sold.

UBS Group first reported a position in NMHI in Q3 2024 and held it in 1 quarter. The position peaked at $15.1K in Q3 2024. 4 funds tracked by Wall St. Rank hold NMHI as of Q4 2024.

  • UBS Group reported no remaining Natures Miracle Holding Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • UBS Group sold 3,624 Natures Miracle Holding Inc. Common Stock shares in Q4 2024, an estimated $15.1K.
  • UBS Group first reported a position in Natures Miracle Holding Inc. Common Stock in Q3 2024 and held it in 1 quarter.
  • UBS Group's Natures Miracle Holding Inc. Common Stock position peaked at $15.1K in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Natures Miracle Holding Inc. Common Stock as of Q4 2024.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.